Chifeng Wedge Pharmaceutical Co., Ltd.

    Chifeng Wedge Pharmaceutical Co., Ltd is an integrated pharmaceutical company comprising of R & D, Pharmaceutical Raw Material Production, Solid and liquor Finished Product Manufacturing and Domestic as well as Foreign Trade. The company was assessed to be the High-New Technology Enterprise and Scientific and Technological Creation Demonstrative Enterprise by Nei Mongol Autonomous Region Technology Office in 2000. Shenzhen Wedge Group is the major shareholder of Chifeng Wedge and its associated companies (Nei Mongol ShuangQi Pharmaceutical Co., Ltd., Shenzhen New Wedge Co., Ltd. and Shengzhen Wedge Pharmaceutical Chain Co., Ltd.) Shenzhen Wedge Group formed a complete industry chain which comprises R & D, production, distribution, marketing and sales for the manufacturing stage through to retail sales. Our culture Vision To become your most trust-worthy and reliable enterprise Personality Honor, Responsibility and Courage in all that we do Style To achieve standards of excellence Guide to interpersonal relationship Being a friend and partner Our Goal To become a top enterprise with the outstanding quality and unsurpassed social reputation in the pharmaceutical and medical industry by 2017. Our Strategies ? To attain and maintain international quality standards ? To deliver efficiency and cost effectiveness in our manufacturing process ? To be a world class company ? International standards of management and staff driven by demands of international customers ? Strive for ongoing technological improvement and innovation Our Products ? Pharmaceutical Raw Materials ? Tablets ? Capsules ? Granules ? Ointments ? Creams ? Solutions and Liniments We have 85 products, many of which have been assessed for the coveted State Torch Program and have won National Science and Technology Awards as well as Certificates of New Excellent Product. Among them is our pharmaceutical raw material Tosufloxacin Tosilate (Tosufloxacin Tosylate) which is a product under National Patent. The tablets are a State Category II New Drug. Our Chinese herb preparation ginseng Fructus Ointment has excellent efficacy in the removal of freckles and lightening of skin. We are the only manufacturer of Zincum Acetylsalicum Capsules which is the Category Ⅳ New Drugs of China. In 2008, our international trade and exports was one third of the total revenue of our company. Our Quality We were accredited the cGMP by the Regulatory Authority of China (SFDA) in 2004. In order to continue our ongoing quality improvement program, we invested a further 70 million Yuan to upgrade our building and effect technological improvements. We built new factories and facilities in accordance with Chinese and international GMP. This resulted in the advancement of our production facilities as well as our quality assurance equipment and instrumentation. In preparation for the entry of our finished product into international markets, we have been introducing international cGMP standards into our manufacturing facilities actively from 2007. Our Future Chifeng Wedge not only has the sense of social responsibility and global ambitions but we are also a company with responsibility to its stake holders, staff and society. The company has been developing rapidly and steadily toward its goals according to its policies, strategies and code of conduct.